Inside the GENOME

In this episode of Inside the GENOME, Dr. Slavin sits down with Elisabeth King, RN, FNP, AGN, AOCNP of City of Hope. They discuss the differences between training and scope among genetics professionals, and how she came into her role as a genetics provider.

About Our Guest:
Elisabeth King, is an Advanced Practice Provider with specialized training in genetics and is the Executive Director of Genomics and Precision Medicine at City of Hope.
https://www.cityofhope.org/elisabeth-king

About This Episode

Dr. Holly Pederson is the director of the Medical Breast services in the breast center at the Cleveland Clinic. She is an Associate Professor at the Cleveland Clinic Lerner College of Medicine. 

She sits down with Dr. Slavin to discuss a newly emerging tool within hereditary cancer genetics: polygenic risk scores.

In this episode, Dr. Slavin sits down with Vincent Chung, MD, City of Hope, to discuss his position at City of Hope as a pancreatic cancer medical oncology expert, coronavirus affects on cancer care, and the role genetics plays for determining certain pancreatic cancer treatments.

About Our Guest: 
Vincent Chung, M.D., is a medical oncologist specializing in pancreatic cancer and other gastrointestinal cancers. He runs many clinical trials with the hopes to improve the lives of patients affected by these cancers.

In this episode, Dr. Slavin sits down with Michael Hall, MD, Fox Chace Cancer Center, to discuss how he got to where he is today, his department of clinical genetics, and how he thinks COVID-19 will change the world of cancer genetics. 

About Our Guest: 
Dr. Michael Hall is Chair and Professor of the Department of Clinical Genetics at Fox Chase Cancer Center. He is a physician-scientist, medical oncologist, and an expert in gastrointestinal cancers, particularly those cause by hereditary syndromes. 

In this episode, Dr. Slavin joined by Shelly Cummings, MS, CGC Director of Myriad Oncology Medical Affairs, speak with Sue Friedman - Founder and Executive Director of the hereditary testing patient advocacy group, Facing Our Risk of Cancer Empowered - F.O.R.C.E. They discuss how FORCE was created, how it has been affected by COVID-19, and what initiatives are currently in the works. 

About F.O.R.C.E.
Facing Our Risk Of Cancer Empowered - F.O.R.C.E. advocates for families facing hereditary breast and ovarian cancer in areas such as access to care, research funding, insurance, and privacy. Learn more here: https://www.facingourrisk.org/ 

In this episode, Dr. Slavin sits down with David C. Weintritt, MD, FACS, to discuss how his practice has been able to adapt patient visits to a telehealth format and how he is navigating the current environment to continue providing a high standard of patient care remotely. 

About Our Guest: 
David C. Weintritt, MD, FACS is Assistant Clinical Professor, Department of Surgery, GW Medical Faculty Associates, Founder, National Breast Center and Foundation, and Director, Inova Mt. Vernon Breast Program. 

In this episode, Dr. Slavin speaks with Dr. Tuya Pal about the opportunities and challenges she has seen from the COVID-19 pandemic surrounding clinical cancer care and research.

About Our Guest:
Dr. Tuya Pal, MD is Associate Director for Cancer Health Disparities and Ingram Associate Professor of Cancer Research at Vanderbilt-Ingram Cancer Center. She is a nationally recognized physician-scientist expert in hereditary cancer genetics. https://www.vicc.org/member/tuya-pal 

Welcome to the Inside the GENOME podcast with Dr. Thomas Slavin, Sr. Vice President of Medical Affairs for Myriad Oncology. In this episode Dr. Slavin discusses the intentions behind creating this casual yet educational podcast about cancer genetics. Enjoy! 

In this episode, Dr. Slavin joined by Shelly Cummings, MS, CGC Director of Myriad Oncology Medical Affairs, speak with Jennifer Klemp - PhD, MPH, MA Associate Professor of Medicine in the Division of Clinical Oncology at the University of Kansas Cancer Center about her experience with telegenetics and the effect that she has seen from the COVID-19 pandemic. 

About Our Guest:
Jennifer Klemp, PhD, MPH, MA Associate Professor of Medicine in the Division of Clinical Oncology and Director of Cancer Survivorship, Co-Program Leader for Cancer Prevention and Control at the University of Kansas Cancer Center. She is the founder and CEO of Cancer Survivorship Training, Inc., an eLearning company supporting healthcare professionals, and is Principal of Cancer Resource Partners, LLC.